Automatic oxygen control for reducing extremes of oxygen saturation: a randomised controlled trial

This is the authors' abstract. We don't add key points for this paper.

OBJECTIVE: <80%) in preterm infants for the time period on invasive ventilation and/or nasal continuous positive airway pressure (NCPAP) delivered by AVEA ventilator. DESIGN: A parallel arm randomised controlled trial. SETTING: A level-III neonatal intensive care unit. PATIENTS: Preterm infants (<33 weeks birth gestation) who received invasive ventilation or NCPAP in the first 72 hours of age. INTERVENTIONS: ) oxygen control. OUTCOMES: <80%). RESULTS: (0.3 (0.0-2) vs 2 (0.6-6); p=0.02). CONCLUSION: in preterm infants receiving respiratory support. TRIAL REGISTRATION NUMBER: NCT04223258.